Arizona made over $1 billion in cannabis sales in 2023.
Adult-use cannabis was legalized in Arizona in 2020 (1). In September 2023, the Grand Canyon state reached $1 billion dollars in cannabis sales and since that time, have surpassed their revenue numbers for the year (2). According to reports from the Arizona Department of Revenue (ADOR) (2), medical cannabis sales are around one-third of adult-use recreational. This tendency has shown itself repeatedly throughout the year and made history in Arizona for the lowest medical cannabis sales to be reported (2).
In September 2023, sales for medical use were under $27 million. The previous month (August 2023) were reported to be $28.7 million in cannabis sales (2). The adult-use program in the state first started in January 2021 (2) and has battled with the medical-use program, often outdoing it since recreational cannabis’s introduction.
Since April 2021 where it was documented to be $73.4 million, medical cannabis has only decreased in sales (2). The highest sales in 2023 in Arizona was $30 million hit in June. The previous year (June 2022) reached $40 million. Since June 2022, medical cannabis sales have not hit or outdone those numbers (2).
The Arizona Department of Revenue constantly updates their revenue numbers. For example, the department originally stated that July 2023 medical cannabis revenue was $26.1 million but increased the month’s total to $27.3 million (2). In regard to recreational cannabis sales, the same month was originally reported as being $77.4 million but has since been updated to $80.5 million (2).
According to the AZ Mirror (2), “The last time recreational and medical sales were anywhere near equal was October 2021, when adult-use sales were $65.8 million and medical sales were $64.4 million. That was the first month that recreational sales outpaced medical sales. The state has collected $2.4 million and $2.2 million in taxes from medical sales in August and September, respectively, and $13.7 million and $12.8 million from recreational sales.”
Arizona receives $16% of excise tax stemming from recreational cannabis sales, on top of the standard sales tax (2). AZ Mirror reported that medical cannabis patients end up paying an estimated 6% in state sales tax and local governments are able to enforce cannabis sales, regardless of recreational or medical use, an additional 2% sales tax (2).
The AZ Mirror also reported that Arizona’s taxes are used in a variety of ways (2), “One-third of those taxes are dedicated to community college and provisional community college districts; 31% to public safety, including police, fire departments, fire districts and first responders; 25% to the Arizona Highway User Revenue Fund; and 10% to the justice reinvestment fund, which is dedicated to providing public health services, counseling, job training and other social services for communities that have been adversely affected and disproportionately impacted by marijuana arrests and criminalization.”
References
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.